The goal isnt to yank the hair out (like waxing does)
Several retrospective cohort studies have explored the association between the use of GLP-1RAs and the risk of intestinal obstruction compared to SGLT2 inhibitors in T2DM patients, with mixed outcomes
They can evaluate injection technique, confirm medication source and storage, assess for infection or contamination, and discuss alternative formulations (oral semaglutide or other GLP-1 options) if injectable discomfort becomes a barrier to consistent dosing
Tesamorelin (Egrifta) is a GHRH analogue approved by the FDA for one narrow indication, HIV-associated lipodystrophy, and has no marketing authorisation anywhere in the EU, EEA or UK after the European application was withdrawn in 2012 [2]
Consideration When Adjusting Changing your day of injection is different from changing your doses
The well-established healthcare infrastructure and widespread access to advanced medications like Semaglutide and Tirzepatide facilitated rapid adoption